Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Burt Zweigenhaft

Health literacy in the time of COVID-19

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Impetus Digital

- PMLiVE

Valneva shares fall as UK cancels COVID-19 vaccine order

The UK government has cancelled a supply agreement for French vaccine maker Valneva’s COVID candidate VLA2001 over an alleged breach of obligations.

- PMLiVE

Dovetail wins Communiqué Agility and Flexibility award at Communiqué 2021

This inaugural award was given to Dovetail amid fierce competition from four other agencies

We are BOLD

BOLDSCIENCE marks its 1-year launch anniversary with record growth

Specialist medical communication agency BOLDSCIENCE has seen demand for its ‘scientifically creative’ service offerings soar over the past year as global pharma and biotech clients search for trusted partners with...

BOLDSCIENCE

Helping Caregivers Stay Organized, Secure, and Informed

Audrey Bond, Founder & CEO of Vaultt, discusses her inspiration behind founding the company, how Vaultt is revolutionizing data-sharing in Canada, common biosecurity and data privacy concerns, her experience with...

Impetus Digital

Transitioning to the “New Normal”: What This Means for Oncology Care

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US...

Impetus Digital

Making Wearable Technology Scalable and Adoptable

Ilaria Varoli, EVP of Myant Inc., explores Textile Computing™ for remote monitoring, health assessments, pediatric and maternal care, temperature regulation, monitoring of athlete performance, and much more.

Impetus Digital

Courageous Conversation ep.12: Not Going Back: How COVID Has Changed Clinical Trials

Natalie Yeadon, CEO & Co-Founder at Impetus Digital, provides insight into how COVID has changed clinical trials.

Impetus Digital

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

Impetus Digital

- PMLiVE

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

The MOVe-AHEAD trial will test whether the drug prevents infection in those living in the same household as someone with confirmed COVID-19

- PMLiVE

FDA’s director and deputy director of its Office of Vaccines Research & Review resign

The departure of director Marion Gruber and deputy director Philip Krause is unexpected

- PMLiVE

GSK/SK bioscience COVID-19 vaccine to enter phase 3 trial

The study will be one of the first global phase 3 trials to compare two different COVID-19 vaccine candidates

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links